STAT Plus: A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents
A second U.S. government agency is now reviewing whether Moderna (MRNA) properly disclosed millions of dollars in federally funded awards in several patents and patent applications the company filed for its vaccines.
The Biomedical Advanced Research and Development Authority is reviewing contracts awarded to the vaccine maker in response to a request from an advocacy group that analyzed dozens of patent applications. To date, BARDA has awarded the company up to $955 million to develop a vaccine based on its mRNA technology that would be jointly invented by the National Institutes of Health.
Continue to STAT Plus to read the full story…
